Across TCGA pan-cancer cohorts, MIR548H3 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR548H3 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR548H3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548H3 expression acts as an unfavorable survival marker, although some lineages such as ESCA and UCS show a favorable association.
KIRC, MESO, and BLCA are the cancer types where MIR548H3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.